Medifast Q3 revenue down 36% to $89.4M; net loss $2.3M; coaches drop 35%

MEDIFAST INC

2025-Q3 EPS reported -$0.05 revenue$310,692,000

Revenue $89.4M vs $140.2M YoY; net loss $0.21 per diluted share vs $0.10 income.
Active earning OPTAVIA coaches fell to 19,500 from 30,000, due to GLP-1 competition.
Gross margin 69.5% vs 75.4% on fixed-cost de-leverage and $180 basis pts for product reformulation.
Q4 2025 guidance: revenue $65M–$80M; diluted loss per share $0.70–$1.25.
Cash & investments $173.5M; no debt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.